Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
<p>Cost-Effectiveness Analysis Of Ceritinib And Alectinib Versus Crizotinib In The Treatment Of Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer</p>
PaperCitations, authors & open-access status
<p>Cost-Effectiveness Analysis Of Ceritinib And Alectinib Versus Crizotinib In The Treatment Of Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer</p> is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 22 citations, 2019 year and gold oa status.
22
Citations
2019
Year
gold
OA Status